PMID: 6409093May 1, 1983Paper

Quantification of NADPH: cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique

The Biochemical Journal
E A ShephardB R Rabin

Abstract

We have developed a specific radioimmunoassay to quantify NADPH: cytochrome P-450 reductase. The assay is based on the use of 125I-labelled NADPH: cytochrome P-450 reductase as the radiolabelled antigen and can detect quantities of this protein in amounts as low as 30 pg. The results of the radioimmunoassay demonstrates that the 2.7-fold increase in enzyme activity in rat liver microsomal membranes after phenobarbital treatment is due to increased amounts of the protein. beta-Naphthoflavone treatment, however, did not alter the activity or the quantity of this enzyme in microsomes. The quantification of NADPH: cytochrome P-450 reductase in the microsomes isolated from control and phenobarbital- and beta-naphthoflavone-treated animals permits the calculation of the ratio of this protein to that of total cytochromes P-450. A molar ratio of 15:1 (cytochromes P-450/NADPH: cytochrome P-450 reductase) was calculated for control and phenobarbital-treated animals. This ratio increased to 21:1 after beta-naphthoflavone treatment. Thus the molar ratio of these proteins in liver microsomes can vary with exposure of the animals to particular xenobiotics.

Citations

Nov 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J BlanckK Ruckpaul
Jan 29, 2013·Pharmacology & Therapeutics·Amit V Pandey, Christa E Flück
Nov 26, 2009·Phytochemistry·Kenneth Jensen, Birger Lindberg Møller
Mar 15, 1990·Toxicology and Applied Pharmacology·D C McMillanJ A Hinson
Jan 22, 1992·Biochemical Pharmacology·A R GoeptarN P Vermeulen
Nov 1, 1993·Journal of Cellular Biochemistry·H TakaharaK Fukuyama
Oct 14, 2004·Gastroenterology·Roben G GielingWouter H Lamers
Oct 17, 2018·Natural Product Reports·Camilla KnudsenTomas Laursen
Jul 1, 1986·The Histochemical Journal·C J Van Noorden, R G Butcher
Jan 1, 1995·Critical Reviews in Toxicology·A R GoeptarN P Vermeulen
Jun 13, 2012·Biological & Pharmaceutical Bulletin·Hiroshi Sugimoto, Yoshitsugu Shiro
Dec 8, 2019·The Journal of Biological Chemistry·Zhong LiWei Zhang
Mar 4, 2017·Current Molecular Biology Reports·Jean-Etienne BassardTomas Laursen
Oct 25, 2001·Archives of Biochemistry and Biophysics·D C LambM A Kaderbhai
Aug 4, 2001·Biochemical and Biophysical Research Communications·D C LambS L Kelly
Apr 6, 2004·Biochimica Et Biophysica Acta·Marat B MuratalievF Ann Walker
Apr 1, 1992·Archives of Biochemistry and Biophysics·E A ShephardI R Phillips
Sep 9, 2009·Bioorganic & Medicinal Chemistry·Eiji NakataHitoshi Hori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.